RE:RE:RE:RE:RE:RE:rising revenue with no additional capital?Ciao, "Don't kid yourself if you don't think the seeds of this merger were not planted years ago..."
Ciao would be upset if this were the case...
- Gilles gets a seat at the table inside AEZS to gain an intimate understanding of AEZS.
- AEZS absorbs the costs of building a portfolio of drug candidates to 'go/no go' decisions for clinical trials.
- AEZS regains full rights to the diagnostic test from Novo Nordisk.
- AEZS advances the diagnostic trial for children until the trial is completed. The trial was expected to be fully enrolled in December. At completion Gilles assesses the market opportunity and deals for the test being negotiated at that time. The test has also been launched in several nations around the world and Gilles could monitor progress. AEZS also received a US Notice of Allowance for a patent for children last year.
When the time is right Gilles pounces...